- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01426217
Reduction in IV Associated Contamination
September 20, 2018 updated by: Dartmouth-Hitchcock Medical Center
Reduction in Intraoperative Lumen Contamination of Standard 3-Way Open Lumen Stopcock Sets Through Use of a Novel, Passive Bundle
The purpose of this study is to investigate whether implementing a novel syringe and IV stopcock cap system impregnated with alcohol will reduce IV catheter bacterial contamination and infections in patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Bacterial contamination of patient intravenous stopcock sets is a common intraoperative event associated with increased patient mortality, possibly via an infectious mechanism.
The most common type of intravenous tubing used in operating rooms is the open lumen stopcock set which lacks a barrier between the environment and intraluminal space, and thus the intravascular space of the patient.
The stopcock connector can be easily contaminated by provider hands due to improper handling of the device and/or contaminated by soiled syringe tips subsequently connected to the device.
Further, the stopcock connector is often left uncapped by the provider and directly exposed to the environment.
Thus, common breaches in intraoperative aseptic practice of healthcare providers can lead to bacterial contamination of the endoluminal space of the open lumen device.
The primary aim of the current study is to assess the efficacy of a passive bundle designed to decrease intravenous stopcock and tubing intraluminal bacterial contamination.
This passive bundle includes two novel interventions, a DOCit station and HubScrub caps.
The HubScrub is designed to clean the needleless connectors and open lumen stopcock systems.
The DOCit station is designed to simultaneously clean the interior and exterior of needle-less luer connectors of syringes with isopropyl alcohol while also providing a method of storage and organization of multiple syringes.
The investigators hypothesize that the application of this passive bundle to the standard open lumen system commonly employed by anesthesia providers in the operating room will significantly reduce bacterial contamination of standard 3-way open lumen stopcock sets and improve patient safety.
Study Type
Interventional
Enrollment (Actual)
594
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth-Hitchcock Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult patient undergoing surgery or procedure in operating room
- Undergoing general anesthesia
Exclusion Criteria:
- Children (age < 18 years)
- Lack of intravenous access
- failure of anesthesia provider to complete training on experimental device
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Control arm using standard of care operating room procedures and equipment
|
|
|
Experimental: Problem Solving Innovations (PSI) Experimental
Implementation of the passive bundle including HubScrub and DocIt
|
Implementation of passive bundle which includes HubScrub and DocIt device into the operating room environment.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence of Bacterial IV Stopcock Lumen Contamination
Time Frame: 48 hours
|
The presence of bacteria in the stopcock lumen was assessed by analyzing swab cultures of the lumens.
Each swab potentially containing bacteria from any of the 3 lumens of the stopcock sets were analyzed
|
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence of Positive Bacterial Culture in IV Stopcock Due to Effluent Contamination
Time Frame: Until positive, up to 5 days
|
Open lumen ports were removed from the patient; sent directly to the anesthesiology microbiology laboratory; connected by the same clinical laboratory scientist to sterile catheters using sterile, aseptic technique; and injected directly into a BacT/Alert 3D system (bioMérieux Inc., Durham, NC) with 2 mL of sterile saline per port.
BacT/Alert is a blood culture system that automatically monitors bacterial growth using colorimetry; a sensor inserted at the bottom of the bottle changes color on detecting the carbon dioxide produced by the growth of the bacteria.
Catheters were then removed, and the bottles were directly incubated in the BacT/Alert system for 5 days or until positive.
Once positive, the liquid in the bottle was examined to identify the organism.
|
Until positive, up to 5 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Bryan S Brindeiro, MD, Dartmouth-Hitchcock Medical Center
- Study Director: Randy W Loftus, MD, Dartmouth-Hitchcock Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Loftus RW, Koff MD, Burchman CC, Schwartzman JD, Thorum V, Read ME, Wood TA, Beach ML. Transmission of pathogenic bacterial organisms in the anesthesia work area. Anesthesiology. 2008 Sep;109(3):399-407. doi: 10.1097/ALN.0b013e318182c855.
- Koff MD, Loftus RW, Burchman CC, Schwartzman JD, Read ME, Henry ES, Beach ML. Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a novel device. Anesthesiology. 2009 May;110(5):978-85. doi: 10.1097/ALN.0b013e3181a06ec3.
- Loftus RW, Muffly MK, Brown JR, Beach ML, Koff MD, Corwin HL, Surgenor SD, Kirkland KB, Yeager MP. Hand contamination of anesthesia providers is an important risk factor for intraoperative bacterial transmission. Anesth Analg. 2011 Jan;112(1):98-105. doi: 10.1213/ANE.0b013e3181e7ce18. Epub 2010 Aug 4.
- Loftus RW, Brindeiro BS, Kispert DP, Patel HM, Koff MD, Jensen JT, Dodds TM, Yeager MP, Ruoff KL, Gallagher JD, Beach ML, Brown JR. Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a passive catheter care system. Anesth Analg. 2012 Dec;115(6):1315-23. doi: 10.1213/ANE.0b013e31826d2aa4. Epub 2012 Nov 9.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
November 1, 2011
Study Completion (Actual)
November 1, 2011
Study Registration Dates
First Submitted
August 29, 2011
First Submitted That Met QC Criteria
August 30, 2011
First Posted (Estimate)
August 31, 2011
Study Record Updates
Last Update Posted (Actual)
October 18, 2018
Last Update Submitted That Met QC Criteria
September 20, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22743
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-operative Infections
-
University of KentuckyDonJoy OrthopedicsCompletedPost-operative Quadriceps Weakness | Post-operative Quadriceps Inhibition | Adherence to Post-operative Treatment | Post-operative Lower Extremity FunctionUnited States
-
Makerere UniversityCompletedPost Operative InfectionsUganda
-
Shanghai Zhongshan HospitalThe First Affiliated Hospital with Nanjing Medical University; Changhai Hospital and other collaboratorsUnknownPost-operative ComplicationChina
-
Boston Medical CenterWithdrawnPneumonia | Post Operative ComplicationsUnited States
-
Hospices Civils de LyonCompletedPost-operative Complications After Colorectal Surgery | Post-operative Complications After Gastric Surgery | Post-operative Complications After Bariatric SurgeryFrance
-
Vanderbilt UniversitySage Products, Inc.CompletedSurgical Site Infections | Post Operative ComplicationUnited States
-
Holy Family Hospital, Nazareth, IsraelRecruitingPost-Operative Hematoma at Operative Site (Diagnosis) | Post-Operative HemorrhageIsrael
-
Tidal Medical TechnologiesRecruiting
-
Nemours Children's ClinicWithdrawnPre Operative Sedation | Mask Acceptance | Post Operative DeleriumUnited States
-
American University of Beirut Medical CenterCompletedPost-Operative Complications | Intra-Operative Ventilatory ManagementLebanon